Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

17.10
Delayed Data
As of Feb 16
 +0.20 / +1.18%
Today’s Change
11.90
Today|||52-Week Range
18.99
+12.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues50.2M109.9M146.0M165.1M
 
 
 
 
 
Cost of Goods Sold1.6M22.9M23.8M16.6M
 
 
 
 
 
Depreciation And Amortization2.8M13.6M11.9M3.0M
 
 
 
 
 
 
Operating ExpensesGross Income45.8M73.5M110.4M145.5M
 
 
 
 
 
General Expenses102.7M113.7M128.9M162.4M
 
 
 
 
 
Research And Development19.2M29.1M29.2M38.5M
 
 
 
 
 
Total Operating Expenses107.1M150.1M164.6M182.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-57.0M-40.2M-18.6M-16.9M
 
 
 
 
 
Extraordinary Credit77.6M0.000.000.00
 
 
Extraordinary Charge-600.0K0.000.000.00
 
 
Other Expenses124.0K320.0K665.0K1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income20.2M-39.9M-17.9M-15.4M
 
 
 
 
 
Income Taxes0.000.00-104.0K-136.0K
 
 
 
Net Income20.2M-39.9M-18.0M-15.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.8M42.3M43.4M44.7M
 
 
 
 
 
Shares To Calculate EPS Diluted36.7M42.3M43.4M44.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.55-$0.94-$0.41-$0.35
 
 
 
 
 
EPS Diluted$0.55-$0.94-$0.41-$0.35